Holen Sie sich die Stockscreener-App
408.18
2.39%
-10.01
Handel nachbörslich:
408.18
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HCA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$418.19
Offen:
$418.11
24-Stunden-Volumen:
1.84M
Relative Volume:
1.12
Marktkapitalisierung:
$90.55B
Einnahmen:
$76.39B
Nettoeinkommen (Verlust:
$7.81B
KGV:
14.04
EPS:
29.0772
Netto-Cashflow:
$7.93B
1W Leistung:
+9.76%
1M Leistung:
+4.04%
6M Leistung:
-15.41%
1J Leistung:
+18.48%
1-Tages-Spanne:
$405.76
$421.31
1-Wochen-Bereich:
$370.00
$421.31
52-Wochen-Spanne:
$342.71
$556.52
Hca Healthcare Inc Stock (HCA) Company Profile
Firmenname
Hca Healthcare Inc
Sektor
Branche
Telefon
(615) 344-9551
Adresse
ONE PARK PLZ, NASHVILLE, TN
Compare HCA vs THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HCA
Hca Healthcare Inc
|
408.18 | 86.43B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
257.62 | 20.96B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
240.96 | 15.17B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.86 | 13.36B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
113.80 | 11.30B | 6.07B | 793.80M | 464.40M | 5.9914 |
Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-10-14 | Fortgesetzt | Goldman | Buy |
| 2025-07-28 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-07-16 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-29 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-11-22 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-03 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-04 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-11 | Herabstufung | Goldman | Buy → Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-19 | Fortgesetzt | JP Morgan | Neutral |
| 2022-07-06 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-03-29 | Eingeleitet | Wells Fargo | Equal Weight |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-12-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-24 | Eingeleitet | UBS | Buy |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-13 | Fortgesetzt | Citigroup | Neutral |
| 2021-04-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-06 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-07-10 | Hochstufung | Goldman | Neutral → Buy |
| 2019-04-23 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-16 | Eingeleitet | UBS | Buy |
| 2018-03-23 | Fortgesetzt | Mizuho | Buy |
| 2018-01-03 | Eingeleitet | Goldman | Neutral |
| 2018-01-03 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-12-20 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2017-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-11-30 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2017-11-06 | Bestätigt | Citigroup | Neutral |
| 2017-11-01 | Bestätigt | Mizuho | Buy |
| 2017-07-26 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-06-28 | Eingeleitet | Argus | Buy |
Alle ansehen
Hca Healthcare Inc Aktie (HCA) Neueste Nachrichten
HCA Healthcare (NYSE:HCA) Results Shift Market Focus - Kalkine Media
Bernstein raises HCA Healthcare stock price target on margin strength By Investing.com - Investing.com Canada
Medical office building planned on expanded HCA Florida Ocala campus - Ocala StarBanner
Report raises concerns over Mission services, Medicare compliance - 828 News Now
HCA Maintains by Mizuho -- Price Target Lowered to $475 - GuruFocus
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and HCA Healthcare (HCA) - The Globe and Mail
HCA Healthcare, Inc. (NYSE:HCA) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - simplywall.st
Mizuho Cuts HCA Healthcare (NYSE:HCA) Price Target to $475.00 - MarketBeat
Is HCA Undervalued? DCF Says Worth $785 - GuruFocus
Quantinno Capital Management LP Has $90.64 Million Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
Eversept Partners LP Sells 16,645 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
First Trust Advisors LP Sells 5,760 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
Tenet Healthcare Tops Q2 Earnings Estimates, Raises 2026 Outlook - TradingView
HCA Maintained by UBS -- Price Target Lowered to $579 - GuruFocus
HCA Healthcare Q2 Results: Revenue rises 8.7% YoY to $20.23 billion - scanx.trade
HCA Maintains Rating by Morgan Stanley -- Price Target Lowered t - GuruFocus
Behind HCA's Q2 Beat: One-Time Medicaid Boost and a Growing Insurance Headwind - Benzinga
Almost all of HCA’s Affordable Care Act patients are going uninsured. Here’s how that affected Q2 - Healthcare Dive
HCA Healthcare Analysts Slash Their Forecasts After Q2 Results - Benzinga
Jordan Fulkerson named CFO of HCA Florida Memorial Hospital - Jacksonville Daily Record
HCA's Health Insurance Exchange Headwinds, Surgical Softness Led to Guidance Reset, RBC Says - marketscreener.com
KeyBanc cuts HCA Healthcare stock price target on weaker HIX dynamics - Investing.com
Truist cuts HCA Healthcare stock price target on weaker guidance - Investing.com
HCA Maintained by Truist Securities -- Price Target Lowered to $495 - GuruFocus
Truist cuts HCA Healthcare stock price target on weaker guidance By Investing.com - Investing.com Canada
UBS Adjusts HCA Healthcare Price Target to $579 From $635, Maintains Buy Rating - marketscreener.com
HCA Healthcare (NYSE:HCA) Earns "Outperform" Rating from Royal Bank Of Canada - MarketBeat
Bernstein Adjusts HCA Healthcare Price Target to $426 From $413, Maintains Market Perform Rating - marketscreener.com
Oppenheimer Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat
HCA Healthcare Reports Second Quarter 2026 Results - marketscreener.com
Oppenheimer Cuts Price Target on HCA Healthcare to $485 From $520, Keeps Outperform Rating - Moomoo
HCA Maintained by Keybanc -- Price Target Lowered to $435 - GuruFocus
KeyCorp Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat
HCA Healthcare (NYSE:HCA) Price Target Cut to $387.00 by Analysts at Barclays - MarketBeat
Robert W. Baird Cuts HCA Healthcare (NYSE:HCA) Price Target to $393.00 - MarketBeat
Deutsche Bank Cuts HCA Healthcare Price Target to $476 From $540, Maintains Buy Rating - marketscreener.com
Truist Trims Price Target on HCA Healthcare to $495 From $535, Keeps Buy Rating - marketscreener.com
KeyBanc Adjusts Price Target on HCA Healthcare to $435 From $475, Maintains Overweight Rating - marketscreener.com
Barclays Adjusts Price Target on HCA Healthcare to $387 From $402, Maintains Equalweight Rating - marketscreener.com
Lazard Asset Management LLC Boosts Stake in HCA Healthcare, Inc. $HCA - MarketBeat
Lombard Odier Asset Management Switzerland SA Takes Position in HCA Healthcare, Inc. $HCA - MarketBeat
Morgan Stanley Adjusts PT on HCA Healthcare to $380 From $425, Maintains Underweight Rating - Moomoo
HCA Healthcare stock edges higher as strong Q2 2026 results support guidance - Ad-hoc-news.de
2,761 Shares in HCA Healthcare, Inc. $HCA Purchased by Caxton Associates LLP - MarketBeat
Bank of Nova Scotia Buys 12,749 Shares of HCA Healthcare, Inc. $HCA - MarketBeat
HCA Healthcare (HCA) Stock Faces Bullish Narrative Test As Net Margin Reaches 8.8% - Sahm
HCA Healthcare (HCA) Faces Third Straight Year Of Mission Health Compliance Concerns - Yahoo Finance
HCA Healthcare Reported Q2 Earnings. Here’s What the Guide Cut Really Means. - TIKR.com
Healthcare of Ontario Pension Plan Trust Fund Has $180.51 Million Stock Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
Lido Advisors LLC Has $5.62 Million Stock Holdings in HCA Healthcare, Inc. $HCA - MarketBeat
Cumberland Partners Ltd Lowers Stake in HCA Healthcare, Inc. $HCA - MarketBeat
Finanzdaten der Hca Healthcare Inc-Aktie (HCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Hca Healthcare Inc-Aktie (HCA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| McAlevey Michael R | EVP & Chief Legal & Admin Off. |
Feb 18 '26 |
Sale |
533.37 |
1,694 |
903,537 |
8,853 |
1.91%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):